Nexium

Nexium belongs to a powerful class of heartburn medicines called proton pump inhibitors. Prescription versions treat serious conditions caused by stomach acid. Over-the-counter (OTC) Nexium has been approved to treat frequent heartburn. Most side effects, such as headache and dry mouth, are minor, but serious health dangers include increased risk of kidney damage, bone fractures and certain types of cancer.

Nexium
Nexium Facts
  1. Uses GERD, erosive esophagitis, Zollinger-Ellison syndrome, stomach ulcers, frequent heartburn (Nexium OTC)
  2. Side Effects/Complications Kidney disease, injury and failure; acute interstitial nephritis (AIN); hip, wrist and spine fractures; C. diff.-associated diarrhea
  3. Manufacturers AstraZeneca (prescription); Teva Pharmaceuticals (generic); Pfizer (OTC); Perrigo (store brand)

Nexium, marketed as “The Purple Pill,” is one of the most widely prescribed drugs in the United States.

Esomeprazole, Nexium’s generic name, is almost chemically identical to omeprazole, the active ingredient in Prilosec. AstraZeneca manufactures prescription versions of both Nexium and Prilosec. Prevacid and Protonix are two other related drugs.

Woman holding Nexium
In 2018, FiercePharma ranked Nexium as the third best-selling drug in the past 25 years. It estimated Nexium sales totaled $72.5 billion through 2017.

Prescription, Generic and OTC Nexium

Nexium comes in several versions. It premiered as a prescription drug. Over-the-counter (OTC), generic and store brands followed.

Prescription Nexium
The FDA approved the prescription version of Nexium on Feb. 20, 2001. AstraZeneca manufactures it.
Generic Nexium
Teva Pharmaceuticals won FDA approval for the first generic Nexium in 2015. Its generic esomeprazole is a prescription drug. At least eight companies manufactured generic Nexium by 2018.
OTC Nexium 24HR
The FDA approved the first over-the-counter Nexium in 2015. The agency approved Nexium 24HR to treat frequent heartburn. Nexium 24HR is chemically identical to prescription Nexium. Pfizer manufactures Nexium 24HR.
Store Brand Nexium 24HR
Perrigo Company PLC won FDA approval for the first store brand version of Nexium 24HR in 2017. The over-the-counter esomeprazole features packaging for the retail outlets that sell it. It is a cheaper alternative to brand-name Nexium 24HR.
Nexium 24hr tablet
Nexium 24HR tablet.

What Is Nexium Used For?

People use prescription Nexium to treat serious stomach acid-related conditions. OTC Nexium treats frequent heartburn.

Nexium Is FDA Approved to Treat:
  • Gastroesophageal reflux disease (GERD)
  • Erosive esophagitis
  • Zollinger-Ellison syndrome
  • Stomach ulcers
  • Frequent heartburn (OTC versions only)

Precautions Before Taking Nexium

People should not take Nexium if they are allergic to esomeprazole magnesium or any of the drug’s other ingredients.

People who have an allergy to any other PPI should not take Nexium. These precautions and any questions about Nexium and other PPIs should be discussed with a medical professional.

Lawsuit Information
Proton pump inhibitors like Nexium have been involved in over 12,000 lawsuits. Learn more.
View Lawsuits

Common Side Effects of Nexium

In addition to potentially life-threatening side effects from Nexium, some less serious side effects are common among patients who use the drug.

Common Nexium Side Effects
  • Abdominal pain
  • Constipation
  • Diarrhea
  • Dry mouth
  • Flatulence
  • Headache
  • Nausea
  • Somnolence (drowsiness or sleepiness)

In clinical trials, less than 1 percent of adults reported dyspepsia, or indigestion. Pediatric side effects can include fast, shallow breathing and vomiting.

Long-Term Use of Nexium

Using Nexium for a long period of time may increase the risk of inflammation of the stomach lining, according to the FDA. At least one study showed long term use of Nexium and other PPIs could also increase the risk of death.

The FDA warns that patients should never take Nexium 24HR for more than 14 days at a time. And they should never take more than three 14-day courses in a year.

Nexium Drug Interactions

People should not take Nexium if they take certain other medicines. They should also avoid Nexium if they take certain dietary supplements.

Nexium interactions can affect how one or both substances perform. People should tell their doctor what drugs and supplements they are taking before using Nexium.

Nexium Can Interact With the Following Products
  • Any product that contains iron
  • Cellcept (mycophenolate mofetil)
  • Coumadin, Jantoven (warfarin)
  • Fortovase (saquinavir)
  • Lanoxin (digoxin)
  • Methotrexate
  • Nizoral (ketoconazole)
  • Plavix (clopidogrel)
  • Pletal (cilostazol)
  • Prograf (tacrolimus)
  • Reyataz (atazanavir)
  • Rimactane, Rifater, Rifamate (Rifampin)
  • St. John’s Wort (hypericum perforatum)
  • Tarceva (erlotinib)
  • Valium (diazepam)
  • Vfend (voriconazole)
  • Viracept (nelfinavir)

When to Stop Taking Nexium

Patients should always speak with their doctor before stopping Nexium. Doctors may prescribe Nexium for long periods of time. Stopping suddenly can trigger a “rebound” effect. This can cause the patient’s condition to return. It can sometimes be worse than the original problem.

A 2018 review in Current Gastroenterology Reports recommended ways to stop Nexium use. A doctor can work out a step-down plan. Patients can take reduced doses over a two-week to month-long schedule. Or a doctor may recommend the patient take Nexium on alternate days.

Dangers from Long-Term Nexium Use

Studies have linked Nexium and other PPIs to several long-term health dangers. Not all these possible Nexium side effects show up in the medicine’s label.

Chronic Kidney Disease & Damage

A 2017 study looked at 125,000 PPI users over five years. Half who developed chronic kidney damage never had kidney problems before taking PPIs. A 2016 study found long-term PPI use nearly doubled a patient’s chance of kidney failure.

Stroke Risk

In 2016, researchers linked PPI use to a 21 percent increased stroke risk. They presented their findings at the American Heart Association’s Scientific Sessions 2016.

Heart Attack Risk

A 2015 study found that PPI use increased heart attack rates from 16 to 21 percent. Researchers published their findings in the journal PLOS One.

Gastric Cancer

A 2017 study found that PPIs may double the risk of gastric cancer in some patients. Researchers found the increased risk among people with previous Helicobacter pylori infections. They published their results in the BMJ journal Gut.

Esophageal Cancer Risk

A 2018 study found that PPIs taken to prevent esophageal cancer may actually cause it. Researchers in Sweden found PPIs may be responsible for five percent of all cases there. They published their results in Cancer Epidemiology.

Learn More About Studies that Link PPIs to Cancer

FDA Warnings About Nexium

The FDA has added at least seven warnings to Nexium labels since 2010. The FDA adds warnings and precautions when evidence shows a drug may cause serious health dangers.

Timeline of FDA Warnings
  • 2016 – LUPUS ERYTHEMATOSUS EVENTS
    Nexium users should call their doctor if they have joint pain, or if they develop a rash on their cheeks or arms that gets worse in the sun.
  • 2014 – PREGNANCY INFORMATION
    Based on animal data, Nexium may cause fetal harm. This happens with very high doses. Doctors and patients should weigh Nexium risks during pregnancy.
  • 2014 – ACUTE INTERSTITIAL NEPHRITIS
    AIN can lead to kidney failure. Kidney problems may happen at any time while taking Nexium. Symptoms to be aware of include a change in urination or sightings of blood in urine.
  • 2014 – VITAMIN B12 DEFICIENCY
    A vitamin B12 deficiency can lead to cognitive difficulties. It may also cause memory loss.
  • 2012 – CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA
    Nexium may increase the risk of developing severe diarrhea. Hospitalized patients face a higher risk. Patients should call a doctor right away if they experience certain symptoms. These include persistent watery stool, stomach pain and fever.
  • 2011 – LOW MAGNESIUM LEVELS
    Low magnesium levels in the blood can happen in some people who take Nexium for at least three months. Nexium users should tell their doctor about certain symptoms. These include seizures, dizziness, jitteriness, tremors, or abnormal or fast heartbeat.
  • 2010/2011 – HIP, WRIST AND SPINE FRACTURES
    People taking multiple, daily Nexium doses for a year or longer may be more prone to bone fractures. The FDA cited studies reporting an increased risk of fractures of the hip, wrist and spine with PPI use.

Nexium Lawsuits

Nexium lawsuits, part of a multidistrict litigation (MDL) in federal court, claim that the medication caused kidney injuries or damage. As of July 2019, the MDL included 12,775 pending lawsuits over Nexium and other PPIs.

Kidney Injuries in Nexium Lawsuits
  • Kidney disease
  • Kidney injury
  • Kidney failure
  • Acute interstitial nephritis (AIN)

Please seek the advice of a medical professional before making health care decisions.

Terry Turner
Written By Terry Turner Writer

Terry Turner has been writing articles and producing news broadcasts for more than 25 years. He covers FDA policy, proton pump inhibitors, and medical devices such as hernia mesh, IVC filters, and hip and knee implants. An Emmy-winning journalist, he has reported on health and medical policy issues before Congress, the FDA and other federal agencies. Some of his qualifications include:

  • American Medical Writers Association (AMWA) and The Alliance of Professional Health Advocates member
  • Centers for Disease Control and Prevention Health Literacy certificates
  • Original works published or cited in Washington Examiner, MedPage Today and The New York Times
  • Appeared as an expert panelist on hernia mesh lawsuits on the BBC
Edited By
Medically Reviewed By

41 Cited Research Articles

  1. Purplepill.com. (2016, October). Important Information About Nexium. Retrieved from https://www.purplepill.com/
  2. Nexium. (n.d.). Safety Information. Retrieved from https://www.purplepill.com/heartburn-relief/nexium-side-effects.html
  3. Nexium24hr.com. (n.d.). Frequently Asked Questions. Retrieved from https://www.nexium24hr.com/us/faq-frequently-asked-questions#topic-411
  4. U.S. Food and Drug Administration. (2014, March). Medication Guide. Retrieved from https://www.fda.gov/downloads/drugs/drugsafety/ucm322355.pdf
  5. Purplepill.com. (2016, October). Approved Uses for Nexium. Retrieved from https://www.purplepill.com/acid-reflux-disease/acid-reflux-causes-triggers.html
  6. National Institute of Diabetes and Digestive and Kidney Diseases. (2013, December). Zollinger-Ellison Syndrome. Retrieved from https://www.niddk.nih.gov/health-information/digestive-diseases/zollinger-ellison-syndrome
  7. American College of Gastroenterology. (2009, February 24). Prevention of NSAID-Related Ulcer Complications. Retrieved from https://gi.org/guideline/prevention-of-nsaid-related-ulcer-complications/
  8. National Institutes of Health. (2017, April 24). Proton pump inhibitors. U.S. National Library of Medicine. Retrieved from https://medlineplus.gov/ency/patientinstructions/000381.htm
  9. U.S. Food and Drug Administration. (2014, December). Highlights of Prescribing Information. Nexium (esomeprazole magnesium) Delayed-Release Capsules, 20 mg and 40 mg; Delayed-Release Oral Suspension, 10 mg, 20 mg, and 40 mg. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022101s014021957s017021153s050lbl.pdf
  10. U.S. Food and Drug Administration. (2012, February 8). FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach-acid drugs known as proton pump inhibitors (PPIs). Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-clostridium-difficile-associated-diarrhea-can-be-associated-stomach
  11. U.S. Food and Drug Administration. (2010, May 25). FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-possible-increased-risk-fractures-hip-wrist-and-spine-use-proton-pump
  12. Skerrett, P.J. (2017, May 4). Vitamin B12 deficiency can be sneaky, harmful. Retrieved from https://www.health.harvard.edu/blog/vitamin-b12-deficiency-can-be-sneaky-harmful-201301105780
  13. Antoniou, T. et al. (2015, April). Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571830/
  14. Lazarus, B. et al. (2016, February). Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26752337
  15. Thompson, D. (2016, February 15). Popular heartburn drugs linked to risk of dementia. Retrieved from https://www.cbsnews.com/news/heartburn-drugs-ppi-prilosec-nexium-prevacid-risk-of-dementia/
  16. Tinker, B. (2016, November 16). Popular heartburn medications linked to higher risk of stroke. Retrieved from https://www.cnn.com/2016/11/15/health/heartburn-medication-stroke-risk/
  17. AstraZeneca. (2016, November 10). Year-to-Date and Q3 2016 Results. Retrieved from https://www.astrazeneca.com/media-centre/press-releases/2016/q3-2016-results.html
  18. Creative Commons. (n.d.). Nexium 20mg. https://pillbox.nlm.nih.gov/assets/large/001865022.jpg
  19. U.S. Food and Drug Administration. (2015, January 26). FDA approves first generic esomeprazole. Retrieved from https://wayback.archive-it.org/7993/20170112222811/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm431648.htm
  20. Gralnek, IM. et al. (2006, December 4). Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17162239
  21. U.S. Food and Drug Administration. (2017, December 31). FDA Adverse Events Reporting System (FAERS) Public Dashboard. Retrieved from https://fis.fda.gov/sense/app/777e9f4d-0cf8-448e-8068-f564c31baa25
  22. Goldstein, F.C. et al. (2017, June 7). Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia. Journal of the American Geriatrics Society. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28590010
  23. Wod, M. et al. (2018, May). Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline. Clinical Gastroenterology and Hepatology. Retrieved from https://www.cghjournal.org/article/S1542-3565%2818%2930103-4/pdf
  24. Oliver, E. (2018, February 15). Extended PPI use not associated with cognitive decline – 4 insights. Becker’s GI & Endoscopy. Retrieved from https://www.beckersasc.com/gastroenterology-and-endoscopy/extended-ppi-use-not-associated-with-cognitive-decline-4-insights.html
  25. Xie, Y. et al. (2017, February 22). Long-Term Kidney Outcomes Among Users of Proton Pump Inhibitors Without Intervening Acute Kidney Injury. Kidney International. Retrieved from http://www.kidney-international.theisn.org/article/S0085-2538%2817%2930005-4/fulltext
  26. Xie, Y. et al. (2016, October). Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27080976
  27. U.S. Food and Drug Administration. (2017, August 18). FDA Approval Letter. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/207193Orig1s000ltr.pdf
  28. Drug Store News. (2017, August 21). Perrigo prepping launch of Nexium 24HR equivalent following FDA OK. Retrieved from https://www.drugstorenews.com/otc/perrigo-prepping-launch-nexium-hr-equivalent-following-fda-ok/
  29. U.S. Food and Drug Administration. (2001, February 20). Drug Approval Package; Nexium (Esomeprazole Magnesium) Delayed-Release Capsules. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21154_Nexium.cfm
  30. U.S. Food and Drug Administration. (2015, November 23). NDA Approval Letter; Nexium 24HR. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/207920Orig1s000ltr.pdf
  31. Salazar, D. (2017, September 27). Perrigo ships first-to-market store-brand Nexium 24HR. Retrieved from: https://www.drugstorenews.com/otc/perrigo-ships-first-market-store-brand-nexium-hr/
  32. U.S. Food and Drug Administration. (2017, August 18). Perrigo Esomeprazole Magnesium Label. Retrieved from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207193Orig1s000lbl.pdf
  33. American Heart Association. (2016, November 15). Popular heartburn medication may increase ischemic stroke risk. EurekAlert. Retrieved from: https://www.eurekalert.org/pub_releases/2016-11/aha-phm110316.php
  34. Shah, N.H. et al. (2015, June 10). Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. PLOS One. Retrieved from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0124653
  35. Cheung, K.S. et al. (2017, October 31). Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. Retrieved from https://gut.bmj.com/content/67/1/28
  36. Brusselaers, N., Engstrand, L. and Lagergren, J. (2018, April). Maintenance proton pump inhibition therapy and risk of oesophageal cancer. Cancer Epidemiology. Retrieved from https://www.sciencedirect.com/science/article/pii/S1877782118300687?via%3Dihub
  37. Jenkins, K. (2018, March 5). Long-Term PPI Use and Increased Esophageal CA Risk. Medscape. Retrieved from https://www.medscape.com/viewarticle/893399#vp_1
  38. Duffy, S. (2018, May 24). Review Provides Recommendations for Effective PPI Discontinuation. MPR. Retrieved from https://www.empr.com/home/news/review-provides-recommendations-for-effective-ppi-discontinuation/
  39. Kim, J., Blackett, J.W. and Jordorkovsky, D. (2018, May 2018). Strategies for Effective Discontinuation of Proton Pump Inhibitors. Current Gastroenterology Reports. Retrieved from https://link.springer.com/article/10.1007%2Fs11894-018-0632-y
  40. Liu, A. (2018, May 14). From old behemoth Lipitor to new king Humira: Best-selling U.S. drugs over 25 years. FiercePharma. Retrieved from https://www.fiercepharma.com/pharma/from-old-behemoth-lipitor-to-new-king-humira-u-s-best-selling-drugs-over-25-years?mkt_tok=eyJpIjoiTURRNFl6bGhNelV5WVRWaCIsInQiOiJUNTczd3ZYMTdBWmY4THNMY09cLzBJajREQWtHb2tPbHlWUjl1bzJsYVJiZHBRQmFrRXU4V3BIaTRrVlZsUjBMNDNUV05valhDTWxRbFEyMU14Z1wvcUJwVlZqRXZqSWxkaGdBNEt1c1htYkNTUXVYTDFTMkh4Qk1pTzcwNXI4WUx4In0%3D&mrkid=66602117
  41. U.S. Judicial Panel on Multidistrict Litigation. (2019, July 16). MDL Statistics Report. Retrieved from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-July-16-2019.pdf
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(855) 893-9504